MICROALBUMINURIA COMO MARCADOR DE RIESGO CARDIOVASCULAR EN PACIENTES DIABÉTICOS

Abstract

Microalbuminuria is defined as persistent elevations of albumin in the urine of 30 mg / day, it is the main parameter used in diabetic patients for clinical evaluation, since in diabetic nephropathy there is a high rate of urinary excretion of albumin, not detectable by routine methods; It also implies an abnormal vascular permeability and presence of atherosclerosis, observational studies and intervention trials, have established that even low levels of albuminuria are associated with increased risk of cardiovascular morbidity and mortality in general, especially in high-risk populations such as diabetics. The objective of this research is to assess microalbuminuria as a marker of cardiovascular risk in diabetic patients who attend the IESS Portoviejo type B health center during the period 2016 - 2017, the methodology was retrospective, transversal, descriptive, qualitative-quantitative, bibliographic, the instrument was the collection of information through the clinical histories generated by the AS 400 system and the instruments used were non-experimental observation and research. In addition, it is expected to educate users to raise awareness about the magnitude of this disease and have a change in their lifestyle in general, this as a contribution to society. The results of the study revealed that the diagnosis of microalbuminuria can be used as an indicator of cardiovascular risk and these results also showed that 220 of the patients under study presented positive microalbuminuria, of which 146 were female and with a higher prevalence. In the ages between 41-80 years, that is, in these patients there is already an excretion rate of albumin in urine due to the inadequate reabsorption of this protein in the kidney glomerulus